3Goldberg NH,Schneeweiss S,Kowal MK. Availability of comparative efficacy data at the time of drug approval in the United States[J].Journal of the American Medical Association,2011,(17):1786-1789.
4Velentgas P,Dreyer NA,Nourjah P. Developing a Protocol for Observational Comparative Effectiveness Research:A User's Guide[M].Rockville MD:Agency for Healthcare Research and Quality (US),2013.1-192.
